XS
AZN icon

XR Securities’s AstraZeneca AZN Stock Holding History

XR Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,688
Closed -$229K – 422
2022
Q4 		$229K Buy
+1,688
New +$212K 0.02% 430
2022
Q1 		– Sell
-4,005
Closed -$467K – 359
2021
Q4 		$467K Buy
4,005
+2,079
+108% +$245K 0.05% 104
2021
Q3 		$231K Sell
1,926
-398
-17% -$46.3K 0.11% 177
2021
Q2 		$278K Sell
2,324
-6,121
-72% -$672K 0.12% 147
2021
Q1 		$840K Sell
8,445
-5,201
-38% -$523K 0.05% 58
2020
Q4 		$1.36M Buy
13,646
+7,001
+105% +$742K 0.09% 28
2020
Q3 		$728K Sell
6,645
-428
-6% -$47.6K 0.06% 35
2020
Q2 		$748K Buy
7,073
+1,752
+33% +$181K 0.09% 46
2020
Q1 		$475K Buy
+5,321
New +$501K 0.03% 64

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

XR Securities's AZN Position: Q1 2023 in Review

XR Securities sold out of AstraZeneca (AZN) in Q1 2023, closing a stake of 1,688 shares — an estimated $229K sold.

XR Securities first reported a position in AZN in Q1 2020 and held it in 9 quarters. The position peaked at $1.36M in Q4 2020. 1,054 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

  • XR Securities reported no remaining AstraZeneca position as of Q1 2023 after selling out during the quarter.
  • XR Securities sold 1,688 AstraZeneca shares in Q1 2023, an estimated $229K.
  • XR Securities first reported a position in AstraZeneca in Q1 2020 and held it in 9 quarters.
  • XR Securities's AstraZeneca position peaked at $1.36M in Q4 2020.
  • 1,054 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on XR Securities's 13F filing for Q1 2023, filed 2 May 2023.